103 related articles for article (PubMed ID: 23145213)
1. High risk HPV DNA subtypes and E6/E7 mRNA expression in a cohort of colposcopy patients from Northern Italy with high-grade histologically verified cervical lesions.
Ca L; A C; E M; D P; S M; J DI; A Z; G G; G B
Am J Transl Res; 2012; 4(4):452-7. PubMed ID: 23145213
[TBL] [Abstract][Full Text] [Related]
2. Preliminary study of the use of E6/E7mRNA detection in screening and triage management of HR-HPV infection during pregnancy.
Yang YM; Wang SJ; Wang FY; Chen R; Xiao Q; Kang N; Liao QP
Ann Transl Med; 2021 Sep; 9(18):1428. PubMed ID: 34733980
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study of HR HPV E6/E7 mRNA and HR-HPV DNA in cervical cancer screening].
Zhao X; Cui Y; Jiang S; Meng Y; Liu A; Wei L; Liu T; Han H; Liu X; Liu F; Li Y
Zhonghua Yi Xue Za Zhi; 2014 Nov; 94(43):3432-5. PubMed ID: 25622677
[TBL] [Abstract][Full Text] [Related]
4. [Detection of high-risk human papillomavirus (HPV) E6 and E7 oncogene transcripts increases the specificity of the detection of a cervical intraepithelial neoplasia (CIN)].
Sotlar K; Diemer D; Stubner A; Menton S; Menton M; Dietz K; Wallwiener D; Bültmann B
Verh Dtsch Ges Pathol; 2005; 89():195-200. PubMed ID: 18035691
[TBL] [Abstract][Full Text] [Related]
5. Detection of HPV E6/E7 mRNA in the diagnosis of cervical cancer and precancerous lesions after kidney transplantation.
Sun J; Yue Y; Li R; Sun Q; Hu C; Ge X; Guan Q
Am J Transl Res; 2021; 13(6):7312-7317. PubMed ID: 34306499
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of DNA and mRNA e6/e7 of human papillomavirus in the evolution of cervical intraepithelial neoplasia grade 2.
Discacciati MG; da Silva ID; Villa LL; Reis L; Hayashi P; Costa MC; Rabelo-Santos SH; Zeferino LC
Biomark Insights; 2014; 9():15-22. PubMed ID: 24812482
[TBL] [Abstract][Full Text] [Related]
7. HPV genotype determination and E6/E7 mRNA detection for management of HPV positive women.
Bruno MT; Ferrara M; Fava V; Rapisarda A; Coco A
Virol J; 2018 Mar; 15(1):52. PubMed ID: 29587778
[TBL] [Abstract][Full Text] [Related]
8. Predictive Value of HPV E6/E7 mRNA Detection on the Outcome of Cervical LSIL.
Cao L; He P; Yang J; Long X; Chen Y; Yan L; Zhou D
Evid Based Complement Alternat Med; 2022; 2022():8747919. PubMed ID: 35978997
[No Abstract] [Full Text] [Related]
9. Evaluation of HPV E6/E7 mRNA Detection in Clinically Suspected Cases of Cervical Cancer with Abnormal Cytology: Time to Upgrade the Screening Protocols.
Sharma B; Lakhanpal V; Singh K; Oberoi L; Bedi PK; Devi P
J Lab Physicians; 2022 Sep; 14(3):336-342. PubMed ID: 36119422
[No Abstract] [Full Text] [Related]
10. Diagnostic performance of HPV E6/E7 mRNA testing towards HPV-DNA testing and p16/Ki67 immunostaining as a biomarker of high-risk HPV recurrence in Greek women surgically treated for their cervical lesions.
Carcea F; Vavoulidis E; Petousis S; Papandreou P; Siarkou CM; Nasioutziki M; Papanikolaou A; Dinas K; Daniilidis A
J Obstet Gynaecol Res; 2021 Oct; 47(10):3607-3617. PubMed ID: 34374179
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic validity of human papillomavirus E6/E7 mRNA test in cervical cytological samples.
Liu TY; Xie R; Luo L; Reilly KH; He C; Lin YZ; Chen G; Zheng XW; Zhang LL; Wang HB
J Virol Methods; 2014 Feb; 196():120-5. PubMed ID: 24216236
[TBL] [Abstract][Full Text] [Related]
12. Quantivirus® HPV E6/E7 RNA 3.0 assay (bDNA) is as sensitive, but less specific than Hybrid Capture 2 test.
Shen Y; Gong J; He Y; Cheng G; Okunieff P; Li X
J Virol Methods; 2013 Feb; 187(2):288-93. PubMed ID: 23201290
[TBL] [Abstract][Full Text] [Related]
13. Clinical performance of the PreTect HPV-Proofer E6/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer.
Ratnam S; Coutlee F; Fontaine D; Bentley J; Escott N; Ghatage P; Gadag V; Holloway G; Bartellas E; Kum N; Giede C; Lear A
J Clin Microbiol; 2010 Aug; 48(8):2779-85. PubMed ID: 20573862
[TBL] [Abstract][Full Text] [Related]
14. Do women with high-risk HPV E6/E7 mRNA test positivity and NILM cytology need colposcopy?
Liu Y; Jin X; Gong Y; Ma Y; Du B; Yang L; Wang Y; Zhu W
Infect Agent Cancer; 2023 Sep; 18(1):54. PubMed ID: 37773080
[TBL] [Abstract][Full Text] [Related]
15. A cohort retrospective study of high-risk HPV recurrence in Greek women after cervical lesion treatment through detection of viral E6/E7 mRNA expression.
Carcea F; Daniilidis A; Vavoulidis E; Nasioutziki M; Papanikolaou A; Dinas K
J BUON; 2020; 25(1):99-107. PubMed ID: 32277620
[TBL] [Abstract][Full Text] [Related]
16. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
Rezhake R; Hu SY; Zhao S; Xu XQ; Zhao XL; Zhang L; Wang Y; Zhang X; Pan QJ; Qiao YL; Zhao FH
Int J Cancer; 2019 Jan; 144(1):34-42. PubMed ID: 29943809
[TBL] [Abstract][Full Text] [Related]
17. HPV detection and measurement of HPV-16, telomerase, and survivin transcripts in colposcopy clinic patients.
Lanham S; Herbert A; Watt P
J Clin Pathol; 2001 Apr; 54(4):304-8. PubMed ID: 11304848
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus E6/E7 mRNA testing has higher specificity than liquid-based DNA testing in the evaluation of cervical intraepithelial neoplasia.
Möckel J; Quaas J; Meisel H; Endres AS; Schneider V
Anal Quant Cytol Histol; 2011 Dec; 33(6):311-5. PubMed ID: 22590808
[TBL] [Abstract][Full Text] [Related]
19. RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus.
Cattani P; Siddu A; D'Onghia S; Marchetti S; Santangelo R; Vellone VG; Zannoni GF; Fadda G
J Clin Microbiol; 2009 Jul; 47(7):2136-41. PubMed ID: 19403762
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus (HPV) E6/E7 mRNA detection in cervical exfoliated cells: a potential triage for HPV-positive women.
Yao YL; Tian QF; Cheng B; Cheng YF; Ye J; Lu WG
J Zhejiang Univ Sci B; 2017 Mar.; 18(3):256-262. PubMed ID: 28271661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
